SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-015688
Filing Date
2022-04-26
Accepted
2022-04-26 16:15:32
Documents
6
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A mnov-def14a_20220614.htm DEF 14A 813076
2 GRAPHIC gtdcx1nzay5r000003.jpg GRAPHIC 3591
3 GRAPHIC gtdcx1nzay5r000001.jpg GRAPHIC 3591
4 GRAPHIC gtdcx1nzay5r000002.jpg GRAPHIC 1643
5 GRAPHIC gtdcx1nzay5r000004.jpg GRAPHIC 1643
6 GRAPHIC gtdcx1nzay5r000005.jpg GRAPHIC 1643
  Complete submission text file 0001564590-22-015688.txt   831559
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33185 | Film No.: 22854524
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences